Insilico Medicine, a pioneer in AI-driven drug discovery, has reached a significant milestone by advancing to Phase III human trials for a drug targeting idiopathic pulmonary...
In a strategic partnership, Takeda has joined forces with Insilico Medicine, based in Hong Kong, to leverage artificial intelligence (AI) in the initial stages of drug...
Subscribe to our weekly newsletter below and never miss the latest News or an exclusive offer.